85-1433-92　［取扱停止］FHIT, Recombinant, Human (Fragile Histidine Triad) 2ug　F4149-50B

特徴

• Cleaves A-5'-PPP-5'A to yield AMP and ADP. Possible tumor suppressor for specific tissues Alterations and deletions of the FHIT (Fragile Histidine Triad) gene are strongly linked to the genesis and establishment of human tumors of the lung, cervix, breast, colon, stomach, and pancreas. In normal cells, FHIT may act as a tumor suppressor.
• Recombinant FHIT shows a band at 43kD on SDS-PAGE commassie blue stained gel.
• Dimers and Aggregates:≤ 1% as determined by coomassie blue SDS-PAGE gel analysis.
• Endotoxin:≤ 0.1ng/ug (IEU/ug) of Human FHIT.
• Storage and Stability:May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：2ug
• Source Antigen：Recombinant, E. coli
• Grade：Highly Purified
• Purity：≥ 90% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified.
• Form：Supplied as a liquid in 50mM Tris-Acetate, pH 7.5, 1mM EDTA, 20% glycerol.
• EU Commodity Code：30021019
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]